Segment Information by Division

January 1 to December 31

 (XLSX:) Download XLS

 

 

 

€ million

 

Silicones

 

Polymers

 

Biosolutions

 

Polysilicon

 

Other

 

Consoli-
dation

 

Group

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

2,243.8

 

1,282.1

 

246.1

 

792.2

 

128.0

 

–

 

4,692.2

Internal sales

 

0.2

 

16.4

 

–

 

–

 

–

 

-16.6

 

–

Total sales

 

2,244.0

 

1,298.5

 

246.1

 

792.2

 

128.0

 

-16.6

 

4,692.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

276.8

 

229.3

 

21.6

 

-147.8

 

-117.6

 

0.5

 

262.8

Depreciation, amortization and impairment losses/reversals

 

111.0

 

41.2

 

16.5

 

152.5

 

82.3

 

–

 

403.5

EBITDA

 

387.8

 

270.5

 

38.1

 

4.7

 

-35.3

 

0.5

 

666.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes: result from investments in joint ventures and associates

 

3.4

 

–

 

–

 

–

 

31.5

 

–

 

34.9

Impairment of fixed assets

 

-0.6

 

–

 

–

 

-0.1

 

-0.3

 

–

 

-1.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset additions1

 

96.9

 

35.6

 

19.9

 

24.9

 

47.1

 

–

 

224.4

Additions to financial assets

 

–

 

–

 

–

 

–

 

0.4

 

–

 

0.4

Asset additions

 

96.9

 

35.6

 

19.9

 

24.9

 

47.5

 

–

 

224.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,644.3

 

673.5

 

223.1

 

1,040.8

 

3,368.9

 

-0.1

 

6,950.5

Liabilities (Dec. 31)

 

955.4

 

390.7

 

109.7

 

577.9

 

3,225.0

 

–

 

5,258.7

Net assets (Dec. 31)

 

688.9

 

282.8

 

113.4

 

462.9

 

143.9

 

-0.1

 

1,691.8

Investments in joint ventures and associates included in net assets (Dec. 31)2

 

45.0

 

–

 

–

 

–

 

554.5

 

–

 

599.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

60.2

 

32.2

 

5.7

 

21.3

 

37.2

 

–

 

156.6

Employees (Dec. 31)

 

5,076

 

1,540

 

764

 

2,180

 

4,723

 

–

 

14,283

Employees (average)

 

5,087

 

1,555

 

756

 

2,239

 

4,764

 

 –

 

14,401

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

2,452.8

 

1,294.2

 

243.0

 

780.0

 

157.6

 

–

 

4,927.6

Internal sales

 

0.2

 

20.9

 

–

 

–

 

–

 

-21.1

 

–

Total sales

 

2,453.0

 

1,315.1

 

243.0

 

780.0

 

157.6

 

-21.1

 

4,927.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

375.3

 

153.7

 

14.0

 

-1,012.9

 

-66.7

 

0.3

 

-536.3

Depreciation, amortization and impairment losses/reversals

 

103.2

 

40.5

 

17.1

 

1,069.8

 

89.1

 

–

 

1,319.7

EBITDA

 

478.5

 

194.2

 

31.1

 

56.9

 

22.4

 

0.3

 

783.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes: result from investments in joint ventures and associates

 

3.2

 

–

 

–

 

–

 

51.1

 

–

 

54.3

Impairment of fixed assets

 

-4.8

 

–

 

–

 

-760.0

 

–

 

–

 

-764.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset additions1

 

193.6

 

62.4

 

13.2

 

35.3

 

75.0

 

–

 

379.5

Additions to financial assets

 

–

 

–

 

–

 

–

 

6.6

 

–

 

6.6

Asset additions

 

193.6

 

62.4

 

13.2

 

35.3

 

81.6

 

–

 

386.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,766.1

 

681.9

 

216.8

 

1,293.2

 

2,533.2

 

-0.2

 

6,491.0

Liabilities (Dec. 31)

 

929.2

 

331.4

 

97.4

 

584.9

 

2,519.1

 

–

 

4,462.0

Net assets (Dec. 31)

 

836.9

 

350.5

 

119.4

 

708.3

 

14.1

 

-0.2

 

2,029.0

Investments in joint ventures and associates included in net assets (Dec. 31)

 

42.7

 

–

 

–

 

–

 

597.7

 

–

 

640.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

65.0

 

33.9

 

6.4

 

30.0

 

38.0

 

–

 

173.3

Employees (Dec. 31)

 

5,267

 

1,630

 

754

 

2,333

 

4,674

 

–

 

14,658

Employees (average)

 

5,293

 

1,623

 

737

 

2,441

 

4,657

 

–

 

14,751

1

Intangible assets; property, plant and equipment; investment property; excluding right-of-use assets

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 23.

2

Includes assets held for sale. The segment data by division are part of the notes.

todo Vorjahresvergleich